SCHEMBL3140885

SCHEMBL3140885

CC(O)C(O)COC(=O)CCCCCCCCC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.54
LMNA P02545 3/20 0.47
KDM4E B2RXH2 1/20 0.47
DUSP3 P51452 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 3/20 0.45
PAM P19021 2/20 0.44
TSHR P16473 4/20 0.43
NFKB1 P19838 1/20 0.43
PMP22 Q01453 1/20 0.43
LPAR6 P43657 1/20 0.42
LPAR1 Q92633 1/20 0.42
LPAR4 Q99677 1/20 0.42
LPAR5 Q9H1C0 1/20 0.42
LPAR2 Q9HBW0 1/20 0.42
LPAR3 Q9UBY5 1/20 0.42
ENPP2 Q13822 1/20 0.42
PRKCA P17252 1/20 0.41
PRKCE Q02156 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11075462 0.87 MAPT (0.42) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL1165277 0.85 MAPT (0.73) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL7115976 0.85 MAPT (0.73) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL28336789 0.84 MAPT (0.49) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL5487490 0.83 MAPT (0.55) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL27216258 0.83 MAPT (0.55) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL15171991 0.83 MAPT (0.46) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL605904 0.83 MAPT (0.70) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL17509584 0.82 LMNA (0.51) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL536470 0.81 MAPT (0.52) MAPTLMNAKDM4EDUSP3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060039980-A1 Process of preparing a biodegradable polymer using an enzyme catalyst and a biodegradable polymer prepared through the process KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2006-02-23 US claimed
US-20140276995-A1 4D Dynamically Contouring Mesh and Sutures NOVO IP, LLC 2014-09-18 US disclosed
US-20130090521-A1 TIMED-RELEASE TENSIONED OR COMPRESSED FIBERS NOVO CONTOUR, INC. (US) 2013-04-11 US disclosed
US-7642075-B2 Process of preparing a biodegradable polymer using an enzyme catalyst and a biodegradable polymer prepared through the process KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-01-05 US disclosed
US-20060039980-A1 Process of preparing a biodegradable polymer using an enzyme catalyst and a biodegradable polymer prepared through the process KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060039980-A1 Process of preparing a biodegradable polymer using an enzyme catalyst and a biodegradable polymer prepared through the process HPD, DERA, ADH1C MAPT 4088/4885LMNA 2352/4885KDM4E 1645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.